POXEL SA (POXEL.PA) Stock Price, Quote, News and Overview
EPA:POXEL - Euronext Paris - Matif - FR0012432516 - Common Stock - Currency: EUR
POXEL.PA Quote, Performance and Key Statistics
EPA:POXEL (7/3/2025, 3:48:30 PM)
0.586
-0.01 (-1.84%)
The current stock price of POXEL.PA is 0.586 EUR. In the past month the price decreased by -10.09%. In the past year, price increased by 23.6%.
POXEL.PA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 4AB.DE | ABBVIE INC | 18.4 | 284.04B | ||
| AMG.DE | AMGEN INC | 14.3 | 135.83B | ||
| GIS.DE | GILEAD SCIENCES INC | 14.34 | 117.34B | ||
| VX1.DE | VERTEX PHARMACEUTICALS INC | N/A | 99.54B | ||
| 1REGN.MI | REGENERON PHARMACEUTICALS | 11.75 | 47.81B | ||
| ARGX.BR | ARGENX SE | 101.1 | 28.09B | ||
| 22UA.DE | BIONTECH SE-ADR | N/A | 22.32B | ||
| IDP.DE | BIOGEN INC | 8.48 | 16.73B | ||
| 0QF.DE | MODERNA INC | N/A | 10.04B | ||
| 1MRNA.MI | MODERNA INC | N/A | 9.97B | ||
| GLPG.AS | GALAPAGOS NV | N/A | 1.62B | ||
| 5CV.DE | CUREVAC NV | 5.62 | 1.02B |
Related stock screener links
About POXEL.PA
Company Profile
Poxel SA is a clinical-stage biopharmaceutical company, which engages in the development of novel treatments for metabolic diseases, including type 2 diabetes and liver diseases, such as non-alcoholic steatohepatitis (NASH). The company is headquartered in Lyon, Auvergne-Rhone-Alpes. The company went IPO on 2015-02-06. The firm develops drugs with a focus on Type 2 diabetes. The firm aims at developing drugs from preclinical to phase 2 clinical proof of concept. Its lead product, Imeglimin, is in clinical phase 2 study for Type 2 diabetes indication. A direct activator of AMPK for the treatment of Type 2 diabetes has started its preclinical development, and other projects in the research phase target diabetes and other metabolic diseases with small molecules that have a disease-modifying mechanism of action. Poxel SAS was spun out from Merck Serono. The firm cooperates with the Laboratory for Fundamental and Applied Bioenergetics, Sumitomo Dainippon Pharma, Joseph Fourier University and Department of Cell Physiology and Metabolism at the University of Geneva, Switzerland, among others.
Company Info
POXEL SA
Imm Le Sunway, 259/261 Avenue Jean Jaures
Lyon AUVERGNE-RHONE-ALPES FR
Employees: 6
Phone: 33437372010
POXEL SA / POXEL.PA FAQ
What is the stock price of POXEL SA today?
The current stock price of POXEL.PA is 0.586 EUR. The price decreased by -1.84% in the last trading session.
What is the ticker symbol for POXEL SA stock?
The exchange symbol of POXEL SA is POXEL and it is listed on the Euronext Paris - Matif exchange.
On which exchange is POXEL.PA stock listed?
POXEL.PA stock is listed on the Euronext Paris - Matif exchange.
What is POXEL SA worth?
POXEL SA (POXEL.PA) has a market capitalization of 31.50M EUR. This makes POXEL.PA a Nano Cap stock.
How many employees does POXEL SA have?
POXEL SA (POXEL.PA) currently has 6 employees.
Is POXEL SA (POXEL.PA) expected to grow?
The Revenue of POXEL SA (POXEL.PA) is expected to grow by 3450% in the next year. Check the estimates tab for more information on the POXEL.PA EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy POXEL SA (POXEL.PA) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of POXEL.PA, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of POXEL.PA, evaluating the profitability, health, valuation and growth aspects
- POXEL SA (POXEL.PA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- POXEL SA (POXEL.PA) Sales and EPS estimates to see what analysts future expectations are.
- POXEL SA (POXEL.PA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- POXEL SA (POXEL.PA) Insider and Institutional Ownership to learn about the owners and their transactions.
- POXEL SA (POXEL.PA) Stock Chart to make your own analysis
- POXEL SA (POXEL.PA) Latest news and press-releases to stay up to date.
Does POXEL SA (POXEL.PA) stock pay dividends?
POXEL.PA does not pay a dividend.
When does POXEL SA (POXEL.PA) report earnings?
POXEL SA (POXEL.PA) will report earnings on 2025-07-04.
What is the Price/Earnings (PE) ratio of POXEL SA (POXEL.PA)?
POXEL SA (POXEL.PA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.42).
POXEL.PA Technical Analysis
ChartMill assigns a technical rating of 7 / 10 to POXEL.PA. When comparing the yearly performance of all stocks, POXEL.PA is one of the better performing stocks in the market, outperforming 98.82% of all stocks.
POXEL.PA Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to POXEL.PA. Both the profitability and financial health of POXEL.PA have multiple concerns.
POXEL.PA Financial Highlights
Over the last trailing twelve months POXEL.PA reported a non-GAAP Earnings per Share(EPS) of -0.42. The EPS increased by 70.95% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -288.21% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
POXEL.PA Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 84% to POXEL.PA. The Buy consensus is the average rating of analysts ratings from 9 analysts.
For the next year, analysts expect an EPS growth of -58.3% and a revenue growth 3450% for POXEL.PA